Industries

Health Care

Coronavirus pandemic threatens to delay potentially life-changing, new medicines

Coronavirus pandemic threatens to delay potentially life-changing, new medicines

By: Berkeley Lovelace Jr.
Source: CNBC
Date of Publication: June 19th, 2020
The coronavirus pandemic postponed the start of clinical trials for potentially life-changing, new medicines. It also could delay the time in which some of those drugs will reach the market as the U.S. Food and Drug Administration faces a potential surge in applications amid a pandemic. The full impact of the postponements for testing new drugs, treatments and vaccines for ailments besides Covid-19 may not be known for months.
CVS Reaches Goal To Open 1,000 Coronavirus Test Sites_Forbes

CVS Reaches Goal To Open 1,000 Coronavirus Test Sites

By: Bruce Japsen
Source: Forbes
Date of Publication: May 28th, 2020
CVS Health Thursday said it is delivering as promised to open 1,000 testing locations for the Coronavirus strain Covid-19.
TAGS:
Quest to Offer Employers Virus Tests to Help in Return to Work - Bloomberg

Quest to Offer Employers Virus Tests to Help in Return to Work

By: Emma Court
Source: Bloomberg
Date of Publication: May 27th, 2020
Quest Diagnostics Inc. is offering services to large employers geared at getting their employees back to work safely, including testing for the novel coronavirus, analytics to monitor symptoms and hotspots, and services like temperature monitoring, the company announced Wednesday.
J&J to begin human trials of COVID-19 vaccine in second half of July

J&J to begin human trials of COVID-19 vaccine in second half of July

By: Saumya Sibi Joseph
Source: Reuters
Date of Publication: June 10th, 2020
Johnson & Johnson said on Wednesday it would start human trials of its potential COVID-19 vaccine in the second half of July, two months earlier than planned, as drugmakers race to develop a shot for the deadly respiratory disease.
CEOs Call in the Coaches as Covid-19 Tests Their Companies_WSJ

CEOs Call in the Coaches as Covid-19 Tests Their Companies

By: Joann S. Lublin
Source: The Wall Street Journal
Date of Publication: May 27th, 2020
Business leaders with long-term leadership coaches say tough feedback has prepared them for the challenges of the pandemic.
AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works

AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works

By: Matthew Herper
Source: Stat News
Date of Publication: June 4th, 2020
The drug giant AstraZeneca said Thursday that it has found partners to manufacture and distribute 2 billion doses of the experimental Covid-19 vaccine created by Oxford University, inking a series of deals with non-government organizations and another manufacturer.
Coronavirus: AstraZeneca to begin making potential vaccine

Coronavirus: AstraZeneca to begin making potential vaccine

Source: BBC News
Date of Publication: June 5th, 2020
Drug company AstraZeneca is to start producing a potential vaccine for coronavirus, its boss has told the BBC.
A COVID-19 vaccine has passed its first human trial. But is it the frontrunner?

A COVID-19 vaccine has passed its first human trial. But is it the frontrunner?

By: Nsikan Akpan
Source: National Geographic
Date of Publication: May 29th, 2020
Moderna Therapeutics has just entered phase two of its clinical trials. Here's how mRNA vaccines work and what the latest developments mean.
Eli Lilly starts human study of a potential coronavirus treatment

Eli Lilly starts human study of a potential coronavirus treatment

By: Reuters
Source: CNBC
Date of Publication: June 1st, 2020
Eli Lilly said on Monday it had started an early-stage trial to test its potential treatment for Covid-19, in the world’s first study of an antibody treatment against the disease.
This Seattle startup just raised $1.1M from Vulcan, others to help hospitals care for COVID-19 patients

This Seattle startup just raised $1.1M from Vulcan, others to help hospitals care for COVID-19 patients

By: Taylor Soper
Source: GeekWire
Date of Publication: May 25th, 2020
Vulcan Capital and other Seattle-area firms invested in a $1.1 million round for MDMetrix, a Seattle startup that helps hospitals manage clinical performance.